Patent · US Active

Crystalline Eltrombopag monoethanolamine salt form D

US11214547B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

F.I.S. Fabbrica Italiana Sintetici S.p.A. · IT

Inventors

Nicolas Tesson · Barcelona, ES
Jordi De Mier Vinue · Esplugues de Llobregat, ES
Paolo Stabile · Montecchio Maggiore, IT
Pierluigi Padovan · Montecchio Maggiore, IT
Matteo De Poli · Montecchio Maggiore, IT
Angelo Restelli · Rescaldina, IT

Key dates

Filing date	Jul 25, 2019
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Jul 25, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Object of the present invention is a better crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D, stable, suitable for pharmaceutical purposes, and with the highest solubility in water and excellent non-hygroscopicity, then the related process and intermediates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.